Presentation of IFN-γ to nitric oxide-producing cells: A novel function for mast cells

Journal of Immunology

Volumn 164, Issue 2, 2000, Pages 573-579

  Brooks, Bernadette ^a   Briggs, David M ^a   Eastmond, Nigel C ^a   Fernig, David G ^a   Coleman, John W ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON RECEPTOR; NITRIC OXIDE; RECOMBINANT GAMMA INTERFERON;

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; FLOW CYTOMETRY; INFLAMMATORY CELL; KNOCKOUT MOUSE; MAST CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

EID: 0034650327     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.2.573     Document Type: Article

References (50)

1. Farrar, M. A., and R. D. Schreiber. 1993. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11:571.
2. Billiau, A. 1996. Interferon-γ: biology and role in pathogenesis. Adv. Immunol. 62:61.
3. Coleman, J. W., M. G. Buckley, M. R. Holliday, and A. G. Morris. 1991. Interferon-γ inhibits serotonin release from mouse peritoneal mast cells. Eur. J. Immunol. 21:2559.
4. Holliday, M. R., E. M. S. Banks, R. J. Dearman, I. Kimber, and J. W. Coleman. 1994. Interactions of IFN-γ with IL-3 and IL-4 in the regulation of serotonin and arachidonate release from mouse peritoneal mast cells. Immunology 82:70.
5. Swieter, M., W. A. Ghali, C. Rimmer, and D. Befus. 1989. Interferon-α/β inhibits IgE-dependent histamine release from rat peritoneal mast cells. Immunology 66: 606.
6. Bissonnette, E. Y., B. Chin, and A. D. Befus. 1995. Interferons differentially regulate histamine and TNF-α in rat intestinal mucosal mast cells. Immunology 86:12.
7. Bissonnette, E. Y., and A. D. Befus. 1990. Inhibition of mast cell-mediated cytotoxicity by IFN-α/β and γ. J. Immunol. 145:3385.
8. Takagi, M., K. Koike, and T. Nakahata. 1990. Antiproliferative effect of IFN-γ on proliferation of mouse connective tissue-type mast cells. J. Immunol. 145: 1880.
9. Eastmond, N. C., E. M. S. Banks, and J. W. Coleman. 1997. Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-γ-induced suppression of exocytosis. J. Immunol. 159:1444.
10. DeSchoolmeester, M. L., N. C. Eastmond, R. J. Dearman, I. Kimber, D. A. Basketter, and J. W. Coleman. 1999. Reciprocal effects of interleukin-4 and interferon-γ on immunoglobulin E-mediated mast cell degranulation: a role for nitric oxide but not peroxynitrite or cyclic guanosine monophosphate. Immunology 96:138.
11. Coleman, J. W., M. R. Holliday, I. Kimber, K. M. Zsebo, and S. J. Galli. 1993. Regulation of mouse peritoneal mast cell secretory function by stem cell factor, IL-3 or IL-4. J. Immunol. 150:556.
12. Lortat-Jacob, H., H. K. Kleinman, and J. A. Grimaud. 1991. High-affinity binding of interferon-γ to a basement membrane complex (Matrigel). J. Clin Invest. 87: 878.
13. Lortat-Jacob, H., and J. A. Grimaud. 1991. Interferon-γ binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule. FEBS Lett. 280:152.
14. Camejo, E. H., B. Rosengren, G. Camejo, P. Sartipy, G. Fager, and G. Bondjers. 1995. Interferon γ binds to extracellular matrix chondroitin-sulfate proteoglycans, thus enhancing its cellular response. Arterioscler. Thromb. Vasc. Biol. 15: 1456.
15. Douglas, M. S., D. A. Rix, J. H. Dark, D. Talbot, and J. A. Kirby. 1997. Examination of the mechanism by which heparin antagonizes activation of a model epithelium by interferon-γ (IFN-γ). Clin. Exp. Immunol. 107:578.
16. Fernandez-Botran, R., J. Yan, and D. E. Justus. 1999. Binding of interferon γ by glycosaminoglycans: a strategy for localization and/or inhibition of its activity. Cytokine 11:313.
17. Lortat-Jacob, H., and J. A. Grimaud. 1992. Binding of interferon-γ to heparan sulfate is restricted to the heparin-like domains and involves carboxylic - but not N-sulfated - groups. Biochim. Biophys. Acta 1117:126.
18. Lortat-Jacob, H., J. E. Turnbull, and J. A. Grimaud. 1995. Molecular organization of the interferon-binding domain in heparan sulfate. J. Biochem. 310:497.
19. Sadir, R., E. Forest, and H. Lortat-Jacob. 1998. The heparan sulfate binding sequence of interferon-γ increased the on rate of the interferon-γ-receptor complex formation. J. Biol. Chem. 273:10919.
20. Daubener, W., S. Nockemann, M. Gutsche, and U. Hadding. 1995. Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-γ. Eur. J. Immunol. 25:688.
21. Rix, D. A., M. S. Douglas, D. Talbot, J. H. Dark, and J. A. Kirby. 1996. Role of glucosaminoglycans in regulation of the immunogenicity of human vascular endothelial cells. Clin. Exp. Immunol. 104:60.
22. Stuehr, D. J., and M. A. Marletta. 1987. Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res. 47:5590.
23. Ding, A. H., C. F. Nathan, and D. J. Stuehr. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal raacrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407.
24. Bentley, A. M., Q. Hamid, D. S. Robinson, E. Schotman, Q. Meng, B. Assoufi, A. B. Kay, and S. R. Durham. 1996. Prednisolone treatment in asthma: reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-γ cytokine gene expression within the bronchial mucosa. Am. J. Respir. Crit. Care Med. 153:551.
25. Anderson, D. F., J. D. MacLeod, S. M. Baddeley, A. S. Bacon, J. I. McGill, S. T. Holgate, and W. R. Roche. 1997. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leukocyte infiltration. Clin. Exp. Allergy 27:1060.
26. Huang, S., W. Hendricks, A. Althage, S. Hemmi, H. Bluethmann, R. Kamijo, J. Vilcek, R. M. Zinkernagel, and M. Aguet. 1993. Immune response in mice that lack the interferon-γ receptor. Science 259:1742.
27. Butterfield, J. H., D. Weiler, G. deWald, and G. J. Gleich. 1988. Establishment of an immature mast cell line from a patient with a mast cell leukemia. Leuk. Res. 12:345.
28. 15N]-labelled nitrate in biological fluids. Anal. Biochem. 126:131.
29. Lipscombe, R. J., A. M. Nakhoul, C. J. Saunderson, and D. R. Coombe. 1998. Interleukin-5 binds to heparin/heparan sulfate: a model for an interaction with extracellular matrix. J. Leukocyte biol. 63:342.
30. Salvemini, D., E. Masini, A. Pistelli, P. F. Mannaioni, and J. Vane. 1991. Nitric oxide: a regulatory mediator of mast cell reactivity. J. Cardiovasc. Pharmacol. 17 (Suppl. 3):S258.
31. Masini, E., D. Salvemini, A. Pistelli, P. F. Mannaioni, and J. R. Vane. 1991. Rat mast cells synthesize a nitric oxide-like factor which modulates the release of histamine. Agents Actions 33:61.
32. Iikura, M., T. Takaishi, K. Hirai, H. Yamada, T. Koshino, and Y. Morita. 1998. Exogenous nitric oxide regulates the degranulation of human basophils and rat peritoneal mast cells. Int. Arch. Allergy Immunol. 115:129.
33. Salvemini, D., E. Masini, E. Anggard, P. F. Mannaioni, and J. Vane. 1990. Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation. Biochem. Biophys. Res. Commun. 169:596.
34. Bissonnette, E. Y., C. M. Hogaboam, J. L. Wallace, and A. D. Befus. 1991. Potentiation of tumor necrosis factor-α-mediated cytotoxicity of mast cells by their production of nitric oxide. J. Immunol. 147:3060.
35. Hogaboam, C. M., A. D. Befus, and J. L. Wallace. 1993. Modulation of rat mast cell reactivity by IL-1β: divergent effects on nitric oxide and platelet-activating factor release. J. Immunol. 151:3767.
36. Ruoslahti, E., and Y. Yamaguchi. 1991. Proteoglycans as modulators of growth factor activities. Cell 64:867.
37. Ramsden, L., and C. C. Rider. 1992. Selective and differential binding of interleukin (IL)-1α, IL-1β, IL-2 and IL-6 to glycosaminoglycans. Eur. J. Immunol. 22:3027.
38. Fernig, D. G., and J. T. Gallagher. 1994. Fibroblast growth factors: an information network controlling tissue growth, morphogenesis and repair. Prog. Growth Factor Res. 5:353.
39. Yard, B. A., C. P. Lorentz, D. Herr, and F. J. Van Der Woude. 1998. Sulfation-dependent down-regulation of interferon-γ-induced major histocompatibility complex class I and II and intercellular adhesion molecule-1 expression on tubular and endothelial cells by glycosaminoglycans. Transplantation 66:1244.
40. Lyon, M., J. A. Deakin, H, Rahmoune., D. G. Fernig, T. Nakamura, and J. T. Gallagher. 1998. Hepatocyle growth factor/scatter factor binds with high affinity to dermatan sulfate. J. Biol. Chem. 273:271.
41. Penc, S. F., B. Pomahac, T. Winkler, R. A. Dorschner, E. Eriksson, M. Hendron, and R. L. Gallo. 1998. Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function. J. Biol. Chem. 273:28116.
42. Vancherot, F., J. Delbe, M. Heroult, D. Barritault, D. G. Fernig, and J. Courty. 1999. Glycosaminoglycans differently bind HARP and modulate its biological activity. J. Biol. Chem. 274:7741.
43. Petersen, F., L. Bock, H.-D. Flad. and E. Brandt. 1998. A chondroitin sulfate proteoglycan on human neutrophtls specifically binds platelet factor 4 and is involved in cell activation. J. Immunol. 161:4347.
44. Suzu, S., F, Kimura, J. Ota, K. Motoyoshi, T. Itoh, Y. Mishima, M. Yamada, and S. Shimamura. 1997. Biological activity of proteoglycan macrophage colony-stimulating factor. J. Immunol. 159: 1860.
45. Gordon, M. Y., G. P. Riley, S. M. Watt, and M. F. Greaves. 1988. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 326:403
46. Tanaka, Y., D. H. Adams, H. H. Hubscher, U. Siebenlistand, and S. Shaw. 1993. T-cell adhesion induced by proteoglycan-immobilized cytokine MIP-1β. Nature 361:79.
47. Hoogewerf, A. J., G. S. V. Kuschert, A. E. I. Proudfoot, F. Borlat, I. Clarke-Lewis, C. A. Power, and T. N. Wells. 1997. Glycosaminoglycans mediate cell surface oligomerization of chemokines. Biochemistry 36:13570.
48. Lortat-Jacob, H., F. Baltzer. and J.-A. Grimaud. 1996. Heparin decreases the blood clearance of interferon-γ and increases its activity by limiting the processing of its carboxyl-terminal sequence. J. Biochem. 271:16139.
49. Gruber, B. L., M. J. Marchese, and R. Kew. 1995. Angiogenic factors stimulate mast-cell migration. Blood 86:2488.
50. Nilsson, G., J. A. Mikovits, D. D. Metcalfe, and D. D. Taub. 1999, Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/interleukin-8RB. Blood 93:2791.